Features
Gabriella Dahlgren, PhD
Janssen Supply Group LLC
Senior Manager, Strategy Deployment and Excellence, PQM
Gabriella Dahlgren, PhD, oversees a team that manages stability for the Janssen SM portfolio. She has been part of the Global Janssen Product Quality organization since 2015, initially focused on leading the development of new procedures and processes to support PAT, real-time release, and CM. She is currently Co-Lead of the ISPE PQLI® Continuous Manufacturing team. Prior to joining Janssen, Gabriella’s experiences included more than 10 years as an analytical chemist in various functions, focused on end-to-end process creation for method development, test method validation, new technology eval-uation to speed up release testing, and hydrophilic coating implementation on new medical devices. She also served as the cross-functional subject matter expert for resolution of production issues as they relate to testing and chemical characterization. She has a PhD in bioanalytical chemistry from the University of Michigan and a BS in chemistry from Southeastern Louisiana University. She has been an ISPE member since 2015.
Related Articles
Features
A unique aspect of the pharmaceutical industry is the pairing of innovation and regulation. For nearly two decades, ISPE’s Product Quality Lifecycle Initiative (PQLI®) has worked at the nexus of...
Technical
Process analytical technology (PAT) is perceived as the main enabler for a robust control strategy with continuous manufacturing (CM) because process analytical technology can aid in implementing continuous manufacturing throughout the entire life cycle. This article discusses quality and regulatory hurdles in the life cycle of a process analytical technology application—including model...
